Clinical Observation on the Efficacy of Acupoint Force Therapy Devices in the Intervention of Chronic Pelvic Pain
Not yet recruitingNot applicableNCT07841171
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The present study is a prospective,single-center, single-arm, pre-post control clinical trial conducted at Peking University Third Hospital. 20 participants will be recruited into CCP group,Clinical outcomes will be evaluated at baseline, one week and two weeks after treatment and two weeks follow-up after treatment termination. The primary outcome measure is the Visual Analogue Scale (VAS) pain score before and after treatment. Secondary outcomes include Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Numerical Rating Scale (NRS), SF-36 Health Survey, Short-form McGill Pain Questionnaire (SF-MPQ), adverse event incidence rate, and analgesic medication use frequency.Adverse events will be assessed at every visit. Both the CRF and web-based electronic database, REDCap (edc.bjmu.edu.cn), will be used to manage individual participant data by two data entry personnel independently. SPSS V.25.0 statistical software was used for analysis. This report describes the study design of the clinical trial.
Study details
- Official title
- Clinical Observation on the Efficacy of Acupoint Force Therapy Devices in the Intervention of Chronic Pelvic Pain
- Conditions
- Interventions
- Device: EMMA Robot-assisted Tuina
- Sponsor
- Peking University Third Hospital
- Start date
- 2026-09-30
- Primary completion
- 2027-03-31
- Sex
- Female
- Age range
- from 20 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Meet the diagnostic criteria for chronic pelvic pain; 2. Disease duration greater than 6 months; 3. Female patients aged 20-50 years; 4. Married or unmarried with history of sexual activity; 5. Not concurrently participating in other clinical studies; 6. Voluntarily participate in this trial and provide signed informed consent. Note: Patients must meet all 6 criteria above to be enrolled in this study. Exclusion Criteria: 1. Altered consciousness, inability to cooperate and complete the study, or presence of psychiatric disorders; 2. Concomitant severe diseases of the cardiovascular, cerebrovascular, hepatic, renal, urinary, digestive, or reproductive systems; 3. Concomitant severe spine-related conditions, such as spinal fracture, spinal infection, severe osteoporosis, spondylolisthesis, or spinal instability; 4. Presence of skin lesions, infections, ulcers, or severe dermatological conditions in the treatment area; 5. Pregnant, planning pregnancy, or lactating women; 6. Abdominal, pelvic, lumbar, or pelvic-related surgery or invasive procedures within the past 12 months; 7. Currently participating in other clinical trials. Note: Individuals meeting any one of the above criteria shall be excluded.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07841171